FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1531456299> ?p ?o ?g. }

• W1531456299 endingPage "3480" @default.
• W1531456299 startingPage "3480" @default.
• W1531456299 abstract "To study the changes of quantitative expression, adhering activity and genomic density polymorphism of complement types in erythrocytes (CR1) of patients with gallbladder carcinoma and the related clinical significance.Polymerase chain reaction (PCR), Hind III restriction enzyme digestion, quantitative assay of CR1 and adhering activity assay of CR1 in erythrocytes were used.The number and adhering activity of CR1 in patients with gallbladder carcinoma (0.738+/-0.23, 45.9+/-5.7) were significantly lower than those in chronic cholecystitis and cholecystolithiasis (1.078+/-0.21, 55.1+/-5.9) and healthy controls (1.252+/-0.31, 64.2+/-7.4) (P<0.01). The number and adhering activity of CR1 in patients with chronic cholecystitis and cholecystolithiasis (1.078+/-0.21, 55.1+/-5.9) were significantly lower than those in healthy controls (1.252+/-0.31, 64.2+/-7.4) (P<0.05). There was a positive correlation between quantitative expression and adhering activity of CR1 (r = 0.79, P<0.01). Compared with those on preoperative day (0.738+/-0.23, 45.4+/-4.9), the number and adhering activity of CR1 in patients with gallbladder carcinoma decreased greatly on the third postoperative day (0.310+/-0.25, 31.8+/-5.1) (P<0.01), and on the first postoperative week (0.480+/-0.25, 38.9+/-5.2) (P<0.01), but they were increased slightly than those on the preoperative day (P>0.05). The number and adhering activity of CR1 recovered in the second postoperative week(0.740+/-0.24, 46.8+/-5.9) (P<0.01) and increased greatly in the third postoperative week (0.858+/-0.35, 52.7+/-5.8) (P<0.01) in comparison with those on the preoperative day and in the first postoperative week. The number and adhering activity of CR1 of gallbladder carcinoma patients with infiltrating, adjacent lymphogenous and distant organ metastases were significantly lower than those of gallbladder carcinoma patients without them (P<0.01). No difference was observed between the patients with gallbladder carcinoma and healthy individuals in the spot mutation rate of CR1 density gene (chi(2) = 0.521, P>0.05). The distribution of expression was 67.8% in high expression genomic type, 24.8% in moderate expression genomic type, and 7.4% in low expression genomic type. The number and adhering activity of CR1 high expression genomic type gallbladder carcinomas (0.749+/-0.22, 42.1+/-6.2) were significantly lower than those of healthy individuals (1.240+/-0.29, 63.9+/-7.2), and were also significantly lower than those of healthy individuals (0.921+/-0.23, 54.8+/-7.1), but no difference was observed between the number and adhering activity of CR1 lower expression genomic type gallbladder carcinomas (0.582+/-0.18, 44.3+/-5.5) and those of healthy individuals (0.610+/-0.20, 45.8+/-5.7) (P>0.05).Defective expression of CR1 in gallbladder carcinoma is mostly acquired through central peripheral mechanisms. The changes in CR1 quantitative expression and adhering activity are consanguineously related to the development and metastasis in gallbladder carcinoma." @default.
• W1531456299 created "2016-06-24" @default.
• W1531456299 creator A5003554962 @default.
• W1531456299 creator A5003831407 @default.
• W1531456299 creator A5027545185 @default.
• W1531456299 creator A5064411870 @default.
• W1531456299 creator A5082662127 @default.
• W1531456299 date "2004-01-01" @default.
• W1531456299 modified "2023-10-18" @default.
• W1531456299 title "Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma" @default.
• W1531456299 cites W1974234228 @default.
• W1531456299 cites W1976093435 @default.
• W1531456299 cites W1983012273 @default.
• W1531456299 cites W1984298041 @default.
• W1531456299 cites W1986849471 @default.
• W1531456299 cites W1993838573 @default.
• W1531456299 cites W1994148959 @default.
• W1531456299 cites W2005484657 @default.
• W1531456299 cites W2008667579 @default.
• W1531456299 cites W2019886944 @default.
• W1531456299 cites W2025535675 @default.
• W1531456299 cites W2032534131 @default.
• W1531456299 cites W2034449071 @default.
• W1531456299 cites W2038732739 @default.
• W1531456299 cites W2048293795 @default.
• W1531456299 cites W2049985336 @default.
• W1531456299 cites W2059922433 @default.
• W1531456299 cites W2091054988 @default.
• W1531456299 cites W2091528862 @default.
• W1531456299 cites W2091769643 @default.
• W1531456299 cites W2092747179 @default.
• W1531456299 cites W2108383782 @default.
• W1531456299 cites W2119991678 @default.
• W1531456299 cites W2153705132 @default.
• W1531456299 cites W2168563465 @default.
• W1531456299 cites W22988421 @default.
• W1531456299 cites W2329652171 @default.
• W1531456299 cites W2335321442 @default.
• W1531456299 cites W2401586406 @default.
• W1531456299 cites W2410264638 @default.
• W1531456299 cites W2418382562 @default.
• W1531456299 cites W2440536410 @default.
• W1531456299 cites W2745068438 @default.
• W1531456299 cites W4255534368 @default.
• W1531456299 cites W2418773525 @default.
• W1531456299 doi "https://doi.org/10.3748/wjg.v10.i23.3480" @default.
• W1531456299 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4576231" @default.
• W1531456299 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15526369" @default.
• W1531456299 hasPublicationYear "2004" @default.
• W1531456299 type Work @default.
• W1531456299 sameAs 1531456299 @default.
• W1531456299 citedByCount "12" @default.
• W1531456299 countsByYear W15314562992012 @default.
• W1531456299 countsByYear W15314562992014 @default.
• W1531456299 countsByYear W15314562992015 @default.
• W1531456299 crossrefType "journal-article" @default.
• W1531456299 hasAuthorship W1531456299A5003554962 @default.
• W1531456299 hasAuthorship W1531456299A5003831407 @default.
• W1531456299 hasAuthorship W1531456299A5027545185 @default.
• W1531456299 hasAuthorship W1531456299A5064411870 @default.
• W1531456299 hasAuthorship W1531456299A5082662127 @default.
• W1531456299 hasBestOaLocation W15314562991 @default.
• W1531456299 hasConcept C104317684 @default.
• W1531456299 hasConcept C126322002 @default.
• W1531456299 hasConcept C142724271 @default.
• W1531456299 hasConcept C2777148285 @default.
• W1531456299 hasConcept C2777546739 @default.
• W1531456299 hasConcept C2780354107 @default.
• W1531456299 hasConcept C48023723 @default.
• W1531456299 hasConcept C55493867 @default.
• W1531456299 hasConcept C63363279 @default.
• W1531456299 hasConcept C71924100 @default.
• W1531456299 hasConcept C86803240 @default.
• W1531456299 hasConcept C90924648 @default.
• W1531456299 hasConceptScore W1531456299C104317684 @default.
• W1531456299 hasConceptScore W1531456299C126322002 @default.
• W1531456299 hasConceptScore W1531456299C142724271 @default.
• W1531456299 hasConceptScore W1531456299C2777148285 @default.
• W1531456299 hasConceptScore W1531456299C2777546739 @default.
• W1531456299 hasConceptScore W1531456299C2780354107 @default.
• W1531456299 hasConceptScore W1531456299C48023723 @default.
• W1531456299 hasConceptScore W1531456299C55493867 @default.
• W1531456299 hasConceptScore W1531456299C63363279 @default.
• W1531456299 hasConceptScore W1531456299C71924100 @default.
• W1531456299 hasConceptScore W1531456299C86803240 @default.
• W1531456299 hasConceptScore W1531456299C90924648 @default.
• W1531456299 hasIssue "23" @default.
• W1531456299 hasLocation W15314562991 @default.
• W1531456299 hasLocation W15314562992 @default.
• W1531456299 hasLocation W15314562993 @default.
• W1531456299 hasOpenAccess W1531456299 @default.
• W1531456299 hasPrimaryLocation W15314562991 @default.
• W1531456299 hasRelatedWork W2072200989 @default.
• W1531456299 hasRelatedWork W2158553646 @default.
• W1531456299 hasRelatedWork W2341890494 @default.
• W1531456299 hasRelatedWork W2347405677 @default.
• W1531456299 hasRelatedWork W2348854237 @default.
• W1531456299 hasRelatedWork W2359039983 @default.

• next